Literature DB >> 22893440

Phenotypic variability of atypical 22q11.2 deletions not including TBX1.

Judith M A Verhagen1, Karin E M Diderich, Grétel Oudesluijs, Grazia M S Mancini, Alex J Eggink, Anna C Verkleij-Hagoort, Irene A L Groenenberg, Patrick J Willems, Frederik A du Plessis, Stella A de Man, Malgorzata I Srebniak, Diane van Opstal, Lorette O M Hulsman, Laura J C M van Zutven, Marja W Wessels.   

Abstract

Interstitial deletions of the chromosome 22q11.2 region are the most common microdeletions in humans. The TBX1 gene is considered to be the major candidate gene for the main features in 22q11.2 deletion syndrome, including congenital heart malformations, (para)thyroid hypoplasia, and craniofacial abnormalities. We report on eight patients with atypical deletions of chromosome 22q11.2. These deletions comprise the distal part of the common 22q11.2 deleted region but do not encompass the TBX1 gene. Ten similar patients with overlapping distal 22q11.2 deletions have been reported previously. The clinical features of these patients are described and compared to those found in the classic 22q11.2 deletion syndrome. We discuss the possible roles of a position effect or haploinsufficiency of distally located genes (e.g., CRKL) in the molecular pathogenesis of the 22q11.2 deletion syndrome.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22893440     DOI: 10.1002/ajmg.a.35517

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  22 in total

1.  A mouse splice-site mutant and individuals with atypical chromosome 22q11.2 deletions demonstrate the crucial role for crkl in craniofacial and pharyngeal development.

Authors:  Kerry A Miller; Tiong Y Tan; Megan F Welfare; Susan M White; Zornitza Stark; Ravi Savarirayan; Trent Burgess; Andrew A Heggie; Georgina Caruana; John F Bertram; John F Bateman; Peter G Farlie
Journal:  Mol Syndromol       Date:  2014-11-08

2.  Neonatal Levels of T-cell Receptor Excision Circles (TREC) in Patients with 22q11.2 Deletion Syndrome and Later Disease Features.

Authors:  Kiran A Gul; Torstein Øverland; Liv Osnes; Lars O Baumbusch; Rolf D Pettersen; Kari Lima; Tore G Abrahamsen
Journal:  J Clin Immunol       Date:  2015-03-27       Impact factor: 8.317

3.  Neural tube defects and atypical deletion on 22q11.2.

Authors:  Chiara Leoni; David A Stevenson; Katherine B Geiersbach; Christian N Paxton; Bryan L Krock; Rong Mao; Alan F Rope
Journal:  Am J Med Genet A       Date:  2014-08-13       Impact factor: 2.802

4.  Implications of COMT long-range interactions on the phenotypic variability of 22q11.2 deletion syndrome.

Authors:  Michael J Zeitz; Paula P Lerner; Ferhat Ay; Eric Van Nostrand; Julia D Heidmann; William S Noble; Andrew R Hoffman
Journal:  Nucleus       Date:  2013-12-05       Impact factor: 4.197

5.  Immunodeficiency in a Patient with 22q11.2 Distal Deletion Syndrome and a p.Ala7dup Variant in the MAPK1 Gene.

Authors:  Ana I Sánchez; Mary A García-Acero; Angela Paredes; Rossi Quero; Rita I Ortega; Jorge A Rojas; Daniel Herrera; Miguel Parra; Karol Prieto; Juana Ángel; Luz-Stella Rodríguez; Juan C Prieto; Manuel Franco
Journal:  Mol Syndromol       Date:  2020-02-05

6.  Functional zebrafish studies based on human genotyping point to netrin-1 as a link between aberrant cardiovascular development and thyroid dysgenesis.

Authors:  Robert Opitz; Marc-Philip Hitz; Isabelle Vandernoot; Achim Trubiroha; Rasha Abu-Khudir; Mark Samuels; Valérie Désilets; Sabine Costagliola; Gregor Andelfinger; Johnny Deladoëy
Journal:  Endocrinology       Date:  2015-01       Impact factor: 4.736

7.  An exploratory study of predisposing genetic factors for DiGeorge/velocardiofacial syndrome.

Authors:  Laia Vergés; Francesca Vidal; Esther Geán; Alexandra Alemany-Schmidt; Maria Oliver-Bonet; Joan Blanco
Journal:  Sci Rep       Date:  2017-01-06       Impact factor: 4.379

Review 8.  The 22q11.2 Microdeletion in Pediatric Patients with Cleft Lip, Palate, or Both and Congenital Heart Disease: A Systematic Review.

Authors:  Diana Cárdenas-Nieto; Maribel Forero-Castro; Clara Esteban-Pérez; Julio Martínez-Lozano; Ignacio Briceño-Balcázar
Journal:  J Pediatr Genet       Date:  2019-10-23

9.  A French multicenter study of over 700 patients with 22q11 deletions diagnosed using FISH or aCGH.

Authors:  Céline Poirsier; Justine Besseau-Ayasse; Caroline Schluth-Bolard; Jérôme Toutain; Chantal Missirian; Cédric Le Caignec; Anne Bazin; Marie Christine de Blois; Paul Kuentz; Marie Catty; Agnès Choiset; Ghislaine Plessis; Audrey Basinko; Pascaline Letard; Elisabeth Flori; Mélanie Jimenez; Mylène Valduga; Emilie Landais; Hakima Lallaoui; François Cartault; James Lespinasse; Dominique Martin-Coignard; Patrick Callier; Céline Pebrel-Richard; Marie-France Portnoi; Tiffany Busa; Aline Receveur; Florence Amblard; Catherine Yardin; Radu Harbuz; Fabienne Prieur; Nathalie Le Meur; Eva Pipiras; Pascale Kleinfinger; François Vialard; Martine Doco-Fenzy
Journal:  Eur J Hum Genet       Date:  2015-10-28       Impact factor: 4.246

10.  22q and two: 22q11.2 deletion syndrome and coexisting conditions.

Authors:  Jennifer L Cohen; Terrence B Crowley; Daniel E McGinn; Carey McDougall; Marta Unolt; Michele P Lambert; Beverly S Emanuel; Elaine H Zackai; Donna M McDonald-McGinn
Journal:  Am J Med Genet A       Date:  2018-09-23       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.